Prognostic Value of Controlled Attenuation Parameter by Transient Elastography-Reference-Cited by-同舟云学术

Prognostic Value of Controlled Attenuation Parameter by Transient Elastography

Published:2017-12 Issue:12 Volume:112 Page:1812-1823
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Liu Ken,Wong Vincent Wai-Sun,Lau Keith,Liu Sienna Du,Tse Yee-Kit,Yip Terry Cheuk-Fung,Kwok Raymond,Chan Alex Yiu-Wa,Chan Henry Lik-Yuen,Wong Grace Lai-Hung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference47 articles.

1. Update of liver fibrosis and steatosis with transient elastography (Fibroscan).;Wong;Gastroenterol Rep,2013

2. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.;Friedrich-Rust;Gastroenterology,2008

3. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.;J Hepatol,2015

4. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.;Sasso;Ultrasound Med Biol,2010

5. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.;Karlas;J Hepatol,2017

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification;Ultrasound in Medicine & Biology;2024-08

2. Exercise in the management of metabolic dysfunction-associated fatty liver disease—is more the answer, or is it just one piece of the puzzle?;Hepatobiliary Surgery and Nutrition;2024-04

3. Noninvasive assessment of liver steatosis with ultrasound techniques;Multiparametric Ultrasound for the Assessment of Diffuse Liver Disease;2024

4. Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations;Life;2023-11-27

5. Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes? Authors' reply;Alimentary Pharmacology & Therapeutics;2023-10-26